Zilong Huang Selected Research

Body Weight (Weight, Body)

6/2018	Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
1/2016	Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zilong Huang Research Topics

Disease

6	Infections 01/2019 - 01/2016
2	Body Weight (Weight, Body) 06/2018 - 01/2016
1	Multiple Sclerosis 03/2024
1	Brain Ischemia (Cerebral Ischemia) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Reperfusion Injury 01/2023
1	Pleuropneumonia 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2018
1	Human Influenza (Influenza) 01/2017

Drug/Important Bio-Agent (IBA)

4	cefquinomeIBA 01/2019 - 01/2016
1	Natalizumab (Tysabri)FDA Link 03/2024
1	Glatiramer Acetate (Copaxone)FDA Link 03/2024
1	Dimethyl FumarateIBA 03/2024
1	Fingolimod Hydrochloride (FTY720)FDA Link 03/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	danofloxacinIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016

Therapy/Procedure

4	Culture Diffusion Chambers 01/2019 - 01/2016
1	Therapeutics 03/2024
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023
1	Semiconductors 01/2017
1	Lasers (Laser) 01/2017
1	Intramuscular Injections 01/2016